Exploring the Limb Implant Market

Sustainable Device

Sustainability by Design in Drug Delivery Devices

Pharma's Almanac

High-Concentration

High-Concentration Biologics Are Redefining Subcutaneous Delivery

Pharma's Almanac

Drug–Device

Designing Formulations Around Devices Rather Than Vice Versa

Pharma's Almanac

DBS

Advancing Deep Brain Stimulation Through Better Targeting and Smarter Devices

Cynthia A. Challener, Ph.D.

Pharma's Almanac

DDCPs

Where Drugs Meet Devices: The Next Phase of Combination Product Innovation

Cynthia A. Challener, Ph.D.

Pharma's Almanac

BBB

Opening the Blood–Brain Barrier: Device-Based Strategies for CNS Drug Delivery

David Alvaro, Ph.D.

Pharma's Almanac

Long-Acting Delivery

Long-Acting Drug Delivery for Chronic Metabolic and Renal Conditions

David Alvaro, Ph.D.

Pharma's Almanac

Autoinjectors

Why Autoinjectors Fail After Phase III — and Why It’s Not a Device Problem

David Alvaro, Ph.D.

Pharma's Almanac

Lubricants

Pioneering Biocompatible Lubricants for Next-Generation Medical Devices

Joseph Sahl

FUCHS Lubricants, Co.

Cell Therapy

Building a Better Cell Therapy CDMO

Kincell Bio

Biologics

HIPRA Biotech Services' End-to-End Biologics Offering

HIPRA Biotech Services

Biotech

Australia: Life Sciences' New Frontier

Mark W. Womack

BioCina